Sunshine Lake Pharma Co., Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- China
- Registered address
- No. 1, Northern Industry Road, Northern Industry Park of Song Shan Lake, Dongguan, Guangdong 523808, China (CHN)
- Operations here
- manufacture
- FDA identifiers
- FEI 3007721552 · DUNS 545391443
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-03-22
- VAIDrug Quality Assurance2017-10-19
- OAIDrug Quality Assurance2015-09-25
- NAIDrug Quality Assurance2014-03-14
- VAIDrug Quality Assurance2011-04-21
Drugs this plant is listed as making
12 distinct drugs across 52 products name this site in their FDA label.
- AzithromycinLannett Company, Inc.
- ClarithromycinLannett Company, Inc.
- entacaponeRising Pharma Holdings, Inc.
- febuxostatLannett Company, Inc.
- Fingolimod hclRising Pharma Holdings, Inc.
- moxifloxacin hydrochlorideSolaris Pharma Corporation
- OlanzapineHEC Pharm USA Inc.
- Olmesartan medoxomilHEC Pharm USA Inc.
- oseltamivir phosphateHEC Pharm USA Inc.
- SildenafilHEC Pharm USA Inc.
- TadalafilHEC Pharm USA Inc.
- TicagrelorOryza Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.